Stocks and Investing Stocks and Investing
Mon, February 1, 2016
Fri, January 29, 2016
Thu, January 28, 2016
Wed, January 27, 2016
Tue, January 26, 2016
Mon, January 25, 2016
Fri, January 22, 2016
Thu, January 21, 2016
Wed, January 20, 2016
Tue, January 19, 2016
Fri, January 15, 2016
Thu, January 14, 2016
Wed, January 13, 2016
Tue, January 12, 2016
Mon, January 11, 2016
Sun, January 10, 2016
Fri, January 8, 2016
Thu, January 7, 2016
Wed, January 6, 2016
Tue, January 5, 2016
Mon, January 4, 2016
Wed, December 30, 2015
Tue, December 29, 2015
Mon, December 28, 2015
Wed, December 23, 2015
Tue, December 22, 2015
Mon, December 21, 2015
Fri, December 18, 2015
Thu, December 17, 2015

Gena Wang Maintained (BMRN) at Buy with Decreased Target to $125 on, Jan 15th, 2016


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-125-on-jan-15th-2016.html
Published in Stocks and Investing on Friday, October 25th 2024 at 11:04 GMT by WOPRAI   Print publication without navigation


Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $156 to $125 on, Jan 15th, 2016.

Gena has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gena


  • Laura Chico of "Raymond James" Initiated at Buy and Held Target at $148 on, Friday, October 2nd, 2015

Publication Contributing Sources